{
    "2020-01-10": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Biotechs punch up talking points leading into big Union Square conference",
                "features": {
                    "keywords": [
                        "Biotechs",
                        "punch",
                        "conference"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-08-15",
                "original_text": "Eli Lilly Made a Deal for Dermira. The Biotech’s Stock Price Shows Investors Expect More.",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Dermira",
                        "deal",
                        "stock price"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-12-31",
                "original_text": "Stocks close lower after Dow briefly tops 29,000 milestone for first time",
                "features": {
                    "keywords": [
                        "stocks",
                        "close",
                        "lower",
                        "Dow",
                        "29,000"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-11-10",
                "original_text": "ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Dermira, Inc.",
                "features": {
                    "keywords": [
                        "Rowley Law PLLC",
                        "Acquisition",
                        "Dermira"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "legal",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-12-15",
                "original_text": "Has Eli Lilly and (LLY) Outpaced Other Medical Stocks This Year?",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "LLY",
                        "medical stocks"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-12-10",
                "original_text": "Eli Lilly to add eczema drug with $1.1 billion deal for Dermira",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "eczema drug",
                        "Dermira",
                        "deal"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-12-05",
                "original_text": "Eli Lilly, Apple, Yum! Brands, Nintendo: Companies to watch",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Apple",
                        "Yum!",
                        "Nintendo",
                        "watch"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "technology",
                        "consumer goods",
                        "entertainment"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-12-12",
                "original_text": "Lilly Says It’s Buying a Biotech With a Dermatitis Drug. Investors Have Other Ideas.",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Buying",
                        "Biotech",
                        "Dermatitis Drug",
                        "Investors"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-01-10",
                "original_text": "Benzinga Pro's Top 5 Stocks To Watch For Fri., Jan. 10, 2020: LLY, JPM, SRNE, ELAN, TWTR",
                "features": {
                    "keywords": [
                        "Benzinga Pro",
                        "Top 5 Stocks",
                        "LLY",
                        "JPM",
                        "SRNE",
                        "ELAN",
                        "TWTR"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "finance",
                        "biotech",
                        "social media"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-12-15",
                "original_text": "Eli Lilly Reports Deal To Buy Dermira For $1.1B",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Dermira",
                        "Deal",
                        "$1.1B"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-12-10",
                "original_text": "Eli Lilly to buy Dermira in a deal valued at $1.1 billion",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "buy",
                        "Dermira",
                        "deal",
                        "$1.1 billion"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-12-12",
                "original_text": "Lilly Announces Agreement to Acquire Dermira",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Agreement",
                        "Acquire",
                        "Dermira"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-12-10",
                "original_text": "Eli Lilly to Buy Skin Treatment Company Dermira for $1.1 Billion",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Buy",
                        "Skin Treatment",
                        "Company",
                        "Dermira",
                        "$1.1 Billion"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-12-10",
                "original_text": "Pre-market Movers - Eli Lilley, Boeing in View",
                "features": {
                    "keywords": [
                        "Pre-market Movers",
                        "Eli Lilley",
                        "Boeing"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "aerospace"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}